Massachusetts-based Curaleaf (CSE: CURA) (OTCQX: CURLF) has settled yet another class action lawsuit filed last year against it over CBD drops sold in Oregon that had THC in them and wound up getting consumers high.
The settlement is at least the second the company has reached in the case of its Select brand CBD drops that, starting in 2021, were found to have THC in them, Law360 reported. Another of the suits was settled last year for about $50,000, the website reported.
The incident, which Curaleaf chalked up to “unintentional human error,” has resulted in at least five lawsuits. The latest settlement deal, with plaintiff Ronald Williamson, is for $100,000 that will be put into a fund for consumers who were affected by the THC-infused drops. Each affected consumer will be able to claim $150-$200 if they purchased Select CBD drops that were mislabeled on or after June 19, 2021.
The Select brand drops in question were sold for a brief period in 2021. About 500 bottles were sold that contained THC despite being labeled as only containing CBD before a product recall was initiated, according to Oregon authorities.
Williamson filed a motion in Oregon federal court recently asking a judge to sign off on the settlement deal, which was reached after several months of negotiations after he originally sued Curaleaf in 2022. Attorneys for Williamson indicated they intend to seek no more than 25% of the fund for court costs and legal fees.